Infections in neutropenic cancer patients

Dr. Bodey completed his undergraduate studies at Lafayette College in Easto n, Pennsylvania. He entered The Johns Hopkins University School of Medicine in 1956. After completing his internship and 1 year of residency at Hopkin s in 1962, he spent 3 years at the National Cancer Institute of the Nationa l institutes of Health. In 1966, he joined the faculty of the University of Texas M.D Anderson Cancer institute in Houston, where he eventually became a professor of Medicine. From 1975 to 1983, he served as chief of the Canc er Chemotherapy Branch in the Department of Developmental Therapeutics and was the first director of the Office of Protocol Research. In 1987 Dr. Bode y was appointed chairman of the Department of Medical Specialties, a post h e held until his retirement in 1995. He is currently emeritus professor in the Department of Medicine in the Section of infectious Disease. Dr. Bodey is the author or coauthor of more than 1000 articles, reviews, book chapter s, and teaching aids. In 1983 and again in 1990, the Institute for Scientif ic Information listed him as one of the 300 most cited authors in the scien tific literature. In addition to his service on numerous U.S. and internati onal committees on cancer chemotherapy and immunocompromised hosts, Dr. Bod ey has been a member of the Lunar Quarantine Operations Team, part of the S pace Flight Biotechnology Teams for the Apollo 11, 12, 13, and 14 flights a t the Manned Spacecraft Center in Houston. Outside of his work in medicine, he has maintained a lifelong commitment to Jesus Christ. He is an elder of the Presbyterian Church and was a trustee of the Medical Benevolence Found ation run by the Presbyterian Church. He has attempted to make his life a r eflection of this biblical passage from Matthew 5: 16: "Let your light shin e before men in such a way that they may see your good works and glorify yo ur Father who is in heaven."